Nitisinone Patent Expiration
Nitisinone is Used for managing hereditary tyrosinemia type 1 (HT-1) when combined with dietary restrictions of tyrosine and phenylalanine. It was first introduced by Swedish Orphan Biovitrum Ab Publ
Nitisinone Patents
Given below is the list of patents protecting Nitisinone, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Nityr | US10328029 | Pharmaceutical composition | Jan 05, 2035 | Cycle |
| Orfadin | US9301932 | Liquid pharmaceutical composition comprising nitisinone | Feb 28, 2033 | Swedish Orphan |
| Orfadin | US5550165 | Pharmaceutical compositions for the treatment of hereditary tyosinemia type I |
Aug 27, 2013
(Expired) | Swedish Orphan |
Nitisinone's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List